Nutritional influences on eye health

Optometry

Volumn 71, Issue 10, 2000, Pages 657-663

  Richer, Stuart ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Age related macular degeneration; Cataracts; Environment; Glaucoma; Macular degeneration; Nutrition

Indexed keywords

EYE DISEASE; HUMAN; INCIDENCE; METHODOLOGY; NUTRITIONAL SUPPORT; OPTOMETRY; REVIEW; STANDARD; UNITED STATES;

EYE DISEASES; HUMANS; INCIDENCE; NUTRITIONAL SUPPORT; OPTOMETRY; UNITED STATES;

EID: 0034293234     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Brevoort P, Cordell. Current status of the U.S. Market for Medicinal Botanicals. American Association of Pharmaceutical Scientists Midwest Regional Meeting. Chicago: May 23, 2000.
2. Meyers D, Maloley, Weeks D. Safety of antioxidant vitamins. Arch Intern Med 1996;156:925-35.
3. Bodenheimer T. Uneasy alliance-clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 342:1539-44.
4. Pelton R, Lavalle JB. The nutritional cost of prescription drugs, 1st ed. Englewood, Colo.: Morton Publishing Company, 2000:250.
5. Goldberg. Biochemistry made ridiculously simple. Miami: Medmaster, Inc., 1993.
6. Berman ER. Aqueous, iris-ciliary body, and trabeculum. In: Biochemistry of the eye. New York: Plenum Press, 1991:151.
7. Maxwell S. Prospects for the use of antioxidant therapies. Drugs 1995;49:345-61.
8. Christen WG, Glynn RJ, Hennekens CH. Antioxidants and age-related eye disease, current and future perspectives. Ann Epidemiol 1996;6:60-6.
9. Chylack LT, Cheng HM. Clinical implications of research on lens and cataract. In: Maisel H, ed. The ocular lens: structure, function, and pathology. New York: Marcel Dekker Inc., 1985.
10. Taylor A, Jacques P, Dorey C. Oxidation and aging: impact on vision. Toxicol Ind Health 1993;9:349-71.
11. Rose RC, Richer SP, Bode AM. Ocular oxidants and antioxidant protection. Proc Soc Exp Biol Med 1998;217: 397-407.
12. Taylor A. Nutritional and environmental influences on the eye. Series in modern nutrition. Boca Raton, Fla.: CRC Press, 1999:285.
13. Newsome D, Miceli M, Liles M, et al. Chapter 4: Antioxidants in the retinal pigment epithelium. In: Progress in retinal and eye research. Great Britain: Pergamon Press Ltd., 1994:101-23.
14. Halliwell B. Oxidative stress, nutrition, and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996;25:57-74.
15. © 2000.
16. Haegerstrom-Portnoy G, Schneck ME, Brabyn JA. Seeing into old age: vision function beyond acuity. Optom Vis Sci 1999;76:141-58.
17. Chylack L. Chapter: Function of the lens and methods of quantifying cataract. In: Taylor A, ed. Nutritional and environmental influences on the eye. Boca Raton, Fla.: CRC Press, 1999:25-52.
18. Chylack L, Leske M, McCarthy D, et al. Lens opacities classification system II (LOGS II). Arch Ophthalmol 1989;107:991-7.
19. Clark JI, Hiraoka T. Chapter 7: Evaluation of anticataract agents. In: Taylor A, ed. Environmental and nutritional influences on eye disease. Boca Raton, Fla.: CRC Press, 1999.
20. Benedik GC, Pande J, Thurston GM, et al. Theoretical and experimental basis for the inhibition of cataract. Progress in retinal and eye research. Great Britain: Elsevier Science Ltd., 1999:391-402.
21. Bunce G. Chapter 6: Animal studies on cataract. In: Taylor A, ed. Nutritional and environmental influences on the eye. Boca Raton, Fla.: CRC Press, 1999:105-15.
22. Sardi B. Eradicating cataracts. Townsend Letter for Doctors ISSN 1525-4283 Port Townsend, Washington. 1995:50-9.
23. Taylor A. Role of nutrients in delaying cataracts. In: Sciences AotNYAo, ed. Beyond deficiency, 1993:221-54.
24. Taylor A, Jacques PF, Epstein EM. Relations among aging, antioxidant status, and cataract. Am J Clin Nutr 1995; 62(suppl):1439s-47s.
25. Taylor A. Nutritional and environmental influences on risk for cataract. In: Taylor A, ed. Nutritional and environmental influences on the eye. Boca Raton, Fla.: CRC Press, 1999:53-93.
26. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. AmJ Clin Nutr 1995;62(suppl):1448s-61s.
27. Crabtree D. Radial distribution of tochopherols in rhesus monkey retina and retinal pigment epithelium-choroid. Invest Ophthalmol Vis Sci 1996;37:61-76.
28. Richer SP. Is there a prevention and treatment strategy for macular degeneration? J AM OPTOM ASSOC 1993; 64:838-50.
29. Richer S and the ARMD Study Group. VA/PUCO Multicenter ophthalmic/nutritional ARMD Study. Part 1: Design, subjects, and procedures. J AM OPTOM ASSOC 1996;67:12-29.
30. Richer S and the ARMD Study Group. Multicenter ophthalmic and nutritional age-related macular degeneration study. Part 2: Antioxidant intervention and conclusions. J AM OPTOM ASSOC 1996;67:30-49.
31. Richer S. Part I: A protocol for the evaluation and treatment of atrophic age-related macular degeneration. J AM OPTOM ASSOC 1999;70:13-23.
32. Owsley C, Jackson GR, Cidecciyan AV, et al. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci 2000; 41:267-73.
33. Midena E. Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 1997;38:469-77.
34. Richer SP. Part II. ARMD-Pilot (case series) environmental intervention data. J AM OPTOM ASSOC 1999; 70:24-36.
35. Sardi B. Glaucoma anti-glaucoma regimen. Townsend Letter for Doctors and Patients 1996:52-65.
36. Papastathopoulos K, Jonas J. Fluorescein angiographic correlation of focal narrowing of retinal arterioles in glaucoma. Br J Ophthalmol 1998;82:48-50.
37. Abelson SB, Erickson K, George M. Therapeutic topics: can we protect the neuroretina? Rev Ophthalmol 1996; 3(9):118-9.
38. Gaspar AZ, Gasser P, Flammer J. The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica 1995;209:11-3.
39. Flores FM. Multiple causes of glaucoma: a role for oxygen-free radicals. Chibret Int J Ophthalmol 1994;10:24-7.
40. Dartmouth Atlas of Health Care: Elderly Need Preventative Care, But Don't Get It. Wall Street Journal (Eastern edition), April 19, 1999:B1.
41. Lane BC. Elevation of intraocular pressure with daily sustained closework stimulus to accommodation, lowered tissue chromium, and dietary deficiency of ascorbic acid. Documenta Ophthalmologica Proceedings Series 1981; 28:149-55.